Harvard epidemiologist Michael Mina makes the engineering case for cheap at-home rapid COVID tests as a public health tool the FDA refuses to unleash.

Michael Mina — A Harvard professor of epidemiology and immunology and medical director at Brigham and Women's Hospital, known as a first-principles engineer-scientist and the leading advocate for mass cheap rapid antigen testing during COVID-19.
Michael Mina argues that cheap paper-strip rapid antigen tests, made by the tens of millions a day, could have stopped COVID-19 transmission by empowering people to know when they are infectious. He explains the difference between diagnostic sensitivity and contagiousness sensitivity, why PCR's lingering positives mislead policy, and how the FDA's framing of tests as medical devices rather than public health tools keeps them expensive and unavailable in the US. The conversation widens into his vision for a 'global immunological observatory' that maps viruses like weather, the unique immunological fingerprint that can identify even identical twins, the threat of engineered viruses, and finally his years as a Buddhist monk in Sri Lanka and reflections on meaning.
Books, products and media the guest or host genuinely endorsed here — with the buy link.
Affiliate link — we may earn a commission at no extra cost to you.
Abbott
“this is uh this is abbott's binex now test and it's really it's pretty simple” — guest 00:43:40Find it on Amazon
Detect (Jonathan Rothberg)
“this test here by a company called detect this is one of jonathan rothberg's companies” — guest 00:35:20Find it on Amazon